Conferences
APCCC 2024: The Best Use of PARP Inhibitors in mCRPC
April 27, 2024
APCCC 2024: How to Manage Side Effects of PARP Inhibitors?
April 27, 2024
APCCC 2024: Cardiovascular Complications in Advanced Prostate Cancer – How to Prevent Them and How to Monitor Patients?
April 27, 2024
APCCC 2024: PSMA Radioligand Therapy – State of the Art
April 27, 2024
APCCC 2024: How Do Non-DDR Genomic Alterations Influence Management of Patients with Advanced Prostate Cancer?
April 27, 2024
APCCC 2024: Who Should Undergo Germline Testing?
April 27, 2024
APCCC 2024: How to Treat Men with Aggressive Variant or Neuroendocrine Prostate Cancer
April 27, 2024
APCCC 2024: Future Changes in the Setting of mHSPC
April 26, 2024
APCCC 2024: How to Manage Patients with Low-Volume on Conventional and High-Volume on Next Generation Imaging
April 26, 2024
APCCC 2024: Management of Frail Patients with mHSPC
April 26, 2024
APCCC 2024: Management of Patients with mHSPC and Early Progression on Combination Therapy
April 26, 2024
APCCC 2024: Genomic Classifiers and Artificial Intelligence as Predictors for Treatment Benefit
April 26, 2024